PANews reported on April 25 that according to The Block, Coeptis Therapeutics announced on Friday that it had reached a merger agreement with Z Squared, a Dogecoin mining company. After the transaction is completed, Z Squared will become a wholly-owned subsidiary of Coeptis, and Coeptis will also transform into an important player in the field of digital asset mining. According to the agreement, Coeptis will acquire Z Squared's 9,000 Dogecoin mining equipment by way of equity swap. The new entity will focus on expanding the scale of Dogecoin mining business. The merger is expected to be completed in the third quarter after regulatory approval and shareholder vote. At the same time, Coeptis will initiate a major reorganization, divesting the biopharmaceutical department focusing on cancer, autoimmune diseases and infectious diseases, allowing it to operate independently, while the technical department will be retained in the new company. The announcement stated that for shareholders, the merger not only brings opportunities to participate in the Dogecoin market, but also maintains its connection with Coeptis' biopharmaceutical assets. Coeptis is listed on Nasdaq with the stock code COEP. Affected by the news of the merger, the company's stock price plummeted by nearly 40%, and its current market value is about US$32 million.